The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eat more plants for influenza resilience: Antibiotic treatment worsens influenza in mice, possibly because the concomitant loss of the microbiota interrupts the production of bioactive metabolites. Steed et al. found that a microbial product, desaminotyrosine (DAT), produced by an obligate clostridial anaerobe from the digestion of plant flavonoids, is beneficial during influenza. DAT enters the bloodstream and triggers type I interferon signaling, which then augments antiviral responses by phagocytic cells. Without DAT, influenza virus causes inflammation and severe disease. Science , this issue p. 498
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.220”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [220]
In the citing paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Cited by
Items 401–500 of 583
The Regulation of Nucleic Acid Vaccine Responses by the Microbiome
Johnson, A. M. F., Hager, K., Alameh, M., Van, P., Potchen, N. B., Mayer-Blackwell, K., Fiore-Gartland, A. J., Minot, S. S., Lin, P. J. C., Tam, Y. K., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300196 · Cited by 6
Stickland metabolism in the gut
Little, A. S., & Light, S. H. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01115-x · Cited by 7
Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertension
Ruffenach, G., Medzikovic, L., Aryan, L., Sun, W., Lertpanit, L., O’Connor, E., Dehghanitafti, A., Hatamnejad, M. R., Li, M., Reddy, S. T., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-03046-z · Cited by 5
Hsieh, Y., Hung, C., Chen, Y., Lin, Y.-T., Chang, K., Chiang, W., Chien, C., Wu, C., Li, L., Yu, J.-S., et al. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343514 · Cited by 5
Silva, C. A. C., Almonte, A. A., & Zitvogel, L. (2025) · Biomolecules · doi:10.3390/biom15040504 · Cited by 6
“It is, therefore, associated with improved ICI treatment outcomes and also overcomes the deleterious effects of ATB [112,114,115].”
Gudi, C. R., Wannemuehler, M. J., & Mansell, T. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115650 · Cited by 7
Wang, J., Chen, H., Huang, M., Du, Y., Zhang, R., Huang, Y., Lin, Y., Pan, R., Wang, Y., Cui, W., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70152 · Cited by 6
“Over the past several decades, an expanding body of literature has highlighted the role of the commensal microbiota in priming IFN-I responses (Steed et al. 2017; Erttmann et al. 2022; Niu et al. 2023).”
Zheng, X., Yang, J., Xu, F., Zhou, Q., Sun, C., Wang, A., Wan, J., Li, J., & Liu, B. (2025) · Aquaculture Reports · doi:10.1016/j.aqrep.2025.103055 · Cited by 5
Bogard, G., Makki, K., Rodrigues, P. B., Tan, J., Molendi‐Coste, O., Barthelemy, J., Descat, A., Bouilloux, F., Lecœur, C., Grangette, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-21363-1 · Cited by 5
“…or antibiotic-treated mice, gnotobiotic systems, fecal microbiota transplantation, and microbial metabolite supplementation, have been used to investigate the causal role of the microbiome on influenza infection 57,86,87 and in shaping metabolite profiles, such as lipids species including PEs 88 .”
Cho, H. W., Byeon, H. W., Park, S. O., Uyangaa, E., Choi, J., Kim, K., & Eo, S. K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03579-0 · Cited by 7
“There has been growing interest in understanding how gut microbiota regulate the host innate immune response, particularly their role in inducing and maintaining IFN-I response prior to viral infection [31–33].”
Horvath, M., Yang, R., Castaneda, D. C., Callender, M., Aiken, E. S., Voigt, A. Y., Caldwell, R., Fachi, J. L., Luccia, B. D., Scholar, Z., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02129-7 · Cited by 6
“Secreted metabolites such as desaminotyrosine (DAT) [52] and secondary bile acids [63] also have been shown to promote IFN-I signaling.”
Perego, M., Fu, S., Cao, Y., Kossenkov, A. V., Meng, Y., Bonner, E. E., Alicea-Torres, K. M., Liu, W., Jiang, Z., Chen, Z., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0921-514rr · Cited by 6
Predicting Phenotypic Diversity from Molecular and Genetic Data
Harel, T. H., Peshes‐Yaloz, N., Bacharach, E., & Gat‐Viks, I. (2019) · Genetics · doi:10.1534/genetics.119.302463 · Cited by 5
Hsueh, P., Wu, K.-A., Yang, C., Hsu, C., Wang, C., Hung, C.-M., Chen, Y., Yu, J., & Wu, C. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.06.022 · Cited by 5
High Dose IFN-β Activates GAF to Enhance Expression of ISGF3 Target Genes in MLE12 Epithelial Cells
Kishimoto, K., Wilder, C. L., Buchanan, J., Nguyen, M., Okeke, C., Hoffmann, A., & Cheng, Q. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651254 · Cited by 7
Meher, M. M., & Afrin, M. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.103024 · Cited by 4
Gioula, G., & Exindari, M. (2026) · Pathogens · doi:10.3390/pathogens15010063 · Cited by 4
“In murine studies, combinations targeting both Gram-positive and Gram-negative organisms markedly reduce short-chain fatty acid availability, blunt type I and type III interferon responses, and delay viral clearance, leading to increased lung injury and mortality [5,26,38].”
Chen, Y., Li, H., Mu, J., Peng, Y., D’Ursi, P., Chen, K., & Zheng, Y. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103178 · Cited by 4
Lu, Z., Xu, W., Guo, Y., He, F., & Zhang, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1400214 · Cited by 4
Ding, J., Xu, J., Wu, H., Li, M., Xiao, Y., Fu, J., Zhu, X., Wu, N., Sun, Q., & Liu, Y. (2024) · Genomics · doi:10.1016/j.ygeno.2024.110969 · Cited by 5
Kaushal, A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05587-9 · Cited by 4
“A microbial phenolic acid, Desaminotyrosine (DAT), is secreted by Clostridium orbiscindens helping rescued the antibiotic treated influenza-infected mice, via 1 IFN signaling increment stopping the lung pathology [53].”
BackgroundSun, Y.-L., Guo, Y., Wang, X. Y., Zhang, Y.-S., Jin, X.-Q., Zheng, J., Chen, Y., Cheng, X., Guo, Y.-H., Li, X., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157033 · Cited by 5
Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?
Rodrigues, P. B., Gomes, A. B. D. S. P., Genaro, L. M., Pascoal, L. B., de Souza, A. P. D., Leal, R. F., & Vinolo, M. A. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-71697-4_7 · Cited by 4
Alterations of Fecal Metabolome Associated with BBIBP-CorV Vaccines against the SARS-CoV-2 Virus
Dong, Y., Shen, Y., Wang, P., Jiao, J., Chen, M., & Li, J. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2804065 · Cited by 4
“[27] to suppress influenza and reduce lung immunopathology.”
BackgroundMinot, S. S., Mayer-Blackwell, K., Fiore-Gartland, A. J., Johnson, A., Self, S. G., Bhatti, P., Yao, L., Liu, L., Sun, X., Jinfa, Y., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2414975 · Cited by 5
“44 A failure to acquire Clostridiales taxa, especially Ruminococcaceae, Lachnospricaeae and Clostridium Cluster XIVa, represents the major deficiency of the Cystic Fibrosis (CF) infant microbiome, a finding that is highly reproducible across multiple independent cohorts, including the most…”
BackgroundChemoproteomics of microbiota metabolites reveals small-molecule agonists for orphan receptor GPRC5APreprint
Zhao, X., Stein, K. R., Chen, V., Griffin, M. E., & Hang, H. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472979 · Cited by 4
de Souza, A. P. D., Singanayagam, A., & Porto, B. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1114581 · Cited by 4
“DAT, for example, has been shown to protect against influenza infection by inducing type I IFN signaling, and the administration of DATproducingbacteria restores immunity against influenza infection in antibiotic-treated mice (5).”
BackgroundCoprophagia in early life tunes expression of immune genes after weaning in rabbit ileum
Cauquil, L., Beaumont, M., Schmaltz-Panneau, B., Liaubet, L., Lippi, Y., Naylies, C., Bluy, L. E., Poli, M., Gress, L., Lencina, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59591-6 · Cited by 4
Aranaz, P., Clavel-Millan, M., Gil‐Cardoso, K., González-Arceo, M., Hernández-González, D., Les, F., Salles, J., Amri, E., Arbonés-Mainar, J. M., Atgié, C., et al. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01130-6 · Cited by 5
“Authors observed that, after oral administration of polyphenols, mice produce nanomoles of desaminotyrosine per gram of faeces and picomoles of desaminotyrosine in their blood, thus highlighting that specific metabolite derived from gut microbiota can exert distal effects [ 189].”
Alshatari, S. S., & Ziarno, M. (2026) · Nutrients · doi:10.3390/nu18111762 · Cited by 5
“Ninth, research should distinguish microbiota-dependent from microbiota-independent effects using antibiotic depletion and germ-free models [63].”
Xiang, J., Taggart, C. C., & Rodgers, A. M. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100364 · Cited by 4
Current understanding of gut microbiota in tackling COVID-19
Sumathi, S. H., Suganya, K., Swathi, K., Sudha, B., & Sneha, S. (2021) · Annals of Phytomedicine An International Journal · doi:10.21276/ap.covid19.2021.10.1.15 · Cited by 3
Myricitrin: Resources, Bioavailability, Bioactivity, and Potential Applications
Geng, Y., Xie, Y., Yu, Y., Li, W., Mou, Y., Chen, F., Xiao, J., Hu, X., Ji, J., & Ma, L. (2023) · Springer eBooks · doi:10.1007/978-3-030-94753-8_11-1 · Cited by 4
Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus
Huang, Y., Zhang, P., Han, S., Hu, B., Zhang, Q., & He, H. (2024) · Virology · doi:10.1016/j.virol.2024.110031 · Cited by 3
Felchle, H., Gissibl, J., Rotgerink, L. L., Nefzger, S. M., Walther, C. N., Timnik, V. R., Combs, S. E., & Fischer, J. C. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100758 · Cited by 5
“…hypothesis is supported by re-sults from Steed et al. that identified DAT in the stool and blood of untreated mice, but not in the stool and only at reduced levels in the blood of ABx-treated dysbiotic mice (of note, Steed et al al. used the same VNAM ABx regimen as utilized in this study) [21].”
InfluentialHawryłkowicz, V., Stasiewicz, B., Maciejewska, D., Sołek-Pastuszka, J., Komorniak, N., Skonieczna‐Żydecka, K., Kley, A. M., & Stachowska, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147899 · Cited by 4
“Desaminotyrosine demonstrated the ability to treat viral infection in mice by increasing the expression of multiple type I IFN-stimulated genes in the lungs by increasing the production of type I IFN in response to viruses [82].”
BackgroundHuman microbiota in dengue infection: A narrative review
Romani, F. E., Luvira, V., Chancharoenthana, W., Albanese, M., Maddaloni, L., Branda, F., D’Amelio, S., Gabrielli, S., Scagnolari, C., Mastroianni, C. M., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107643 · Cited by 3
Ai, R., Jin, Y., Zhang, F., Cui, B., & Ji, G. (2025) · Journal of Biomedical Research · doi:10.7555/jbr.39.20250036 · Cited by 2
Hagihara, M., Yamashita, M., Ariyoshi, T., Minemura, A., Yoshida, C., Higashi, S., Oka, K., Takahashi, M., Ota, A., Maenaka, A., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113502 · Cited by 2
Zeng, D., Zhou, H., Wan, H., & Chen, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1532108 · Cited by 2
Xiao, L., Li, Y., Lian, H., Liu, X., Wen, Y., Chen, X., Huang, W., Bi, L. M., Luo, L., Wang, X., et al. (2025) · Animal Microbiome · doi:10.1186/s42523-025-00475-z · Cited by 2
Tetrandrine enhances cognition in SAH rats via gut microbiota CYP51 and TLR4 signaling
Liu, H., Zou, Q., Xiang, T., Zhu, R., Chen, Z., & Chen, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-22980-6 · Cited by 3
Nie, W., Wang, M., Cheng, M., Ren, Z., Liu, C., Liu, C., Huang, Y., Yu, H., Ji, S., Shen, G., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120891 · Cited by 2
Huang, H., Bu, H., Liao, L., Xiang, Y., Chen, Q., Fu, G., Cheng, W., Kou, Y., Liu, Z.-Z., Zheng, K., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2587400 · Cited by 2
“4 It exhibits multifaceted biological functions, including enhanced antimicrobial defense, 9,10 synergistic effects with cancer immunotherapies, 11 and anti-inflammatory and antioxidative properties, as demonstrated in obesity-associated inflammation, colitis, and bacterial endotoxin-induced septic…”
Zhang, Y., Zhang, Y., Wang, L. J., Liu, B., Zheng, J., Cao, J., Xie, L., Shen, N. N., & Wang, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1761517 · Cited by 2
Li, Z., & Zhang, G. Q. (2026) · European journal of medical research · doi:10.1186/s40001-026-04401-0 · Cited by 2
“It was initially considered to be protective in influenza by enhancing type I interferon (IFN) response [110], and recent investigations have positioned DAT to be protective in both the oral infection model [113] and myocardial ischemia/reperfusion (I/R) model [112].”
The interaction between microbes and cytokines in cancer: unraveling the underlying effects
Li, Y., Zhu, Y., Zhang, F., Huang, C. L., & Wang, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08174-2 · Cited by 3
“Desaminotyrosine (DAT), a metabolite of Clostridium orbiscindens , binds to type I IFN or its receptor, thereby affecting the IFN signaling pathway [44].”
Lee, S., Dobeš, P., Bergo, A. M., Marciniak, J., Hurychová, J., Šreibr, S., Kamler, M., Purnoch, V., Killer, J., Hlinakova, L., et al. (2026) · mSystems · doi:10.1128/msystems.00283-26 · Cited by 2
“DAT, a microbial catabolite of tyrosine and flavonoids, is recognized for its immunomodulatory effects in mammals (85–87), although it remains undescribed in honey bee gut metabolites studies (16, 22).”
Immunology: How the Microbiota Digests Bile to Protect against Viral Infection
Klag, K. A., & Round, J. L. (2020) · Current Biology · doi:10.1016/j.cub.2020.08.044 · Cited by 2
Commensal bacteria inhibit viral infections via a tryptophan metabolite
Jiang, D., Soo, N., Tan, C. Y., Dankwa, S., Wang, H.-Y., Theriot, B. S., Xue, K., Hill, D., Ardeshir, A., Bain, J. R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76412-8 · Cited by 3
Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment
Khan, M., Dong, Y., Ullah, R., Li, M., Huang, Q., Hu, Y., Li, Y., & Luo, Z. Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401076 · Cited by 2
Broad-Spectrum Virus Elimination by Nasal Mucosa-Colonized Wild-Type Bacillus subtilis
Li, Y., Yang, C., Tang, R., Wang, C., Li, Y., Chao, W., Cui, A., Liang, C., Duan, Y., Zeng, H., et al. (2025) · Research · doi:10.34133/research.0781 · Cited by 3
“Based on the results of untargeted metabolomics and the relevant literature, 8 metabolites with potential antiviral activities were identified: daidzein, atropine, benzoic acid, α -tocopherol, resveratrol, desaminotyrosine, biochanin A, and piceatannol [ 51 , 63 – 66 ].”
Influence of Commensal Microbiota and Metabolite for Mucosal Immunity
Pope, J. L., Tomkovich, S., & Jobin, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00009-2 · Cited by 3
Interactions of Microbiome for Gut-Brain Axis Health
Lahiri, D., Nag, M., Dey, A., Sayyed, R. Z., & Ray, R. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_5 · Cited by 2
Microbiome in Influenza-A Virus Infection
Awati, S. S., Singh, S. K., Raizaday, A., Kumar, P., Singh, Y. P., Shaikh, M. A. J., & Gupta, G. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_16 · Cited by 2
Fecal Transplantation in Hematopoietic Transplantation
Peled, J. U., & van den Brink, M. R. M. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01169 · Cited by 2
Beyond antiviral: Interferon induced by bacteria maintains tolerance in the gut
Yang, Y., & Cadwell, K. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20232011 · Cited by 3
Mphephu, M. M., Olaokun, O. O., Mavimbela, C., Hofmeyr, G. J. G., Mwale, M., & Mkolo, N. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300319 · Cited by 2
Targeting RIG-I or STING promotes epithelial regeneration
Fischer, J. C., & Poeck, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22994 · Cited by 2
Assigning function to symbionts
Stappenbeck, T. S. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0088-0 · Cited by 2
Self-citationElectron transfer proteins in gut bacteria yield metabolites that circulate in the hostPreprint
Liu, Y., Chen, H., Treuren, W. V., Hou, B., Higginbottom, S. K., Sonnenburg, J. L., & Dodd, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.11.873224 · Cited by 2
Editorial overview: The virome in health and disease
Cadwell, K., & Wang, D. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.06.001 · Cited by 2
Probiotics in treatment of respiratory viral infections
Baryshnikova, N. V. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-11-6-12 · Cited by 1
Ding, M., Yang, B. K., Li, B., Chen, H., Yu, R., Paul, R. R., Stanton, C., Jiang, S., Zhao, J., & Chen, W. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250025 · Cited by 2
Chen, B., Song, T.-T., Hao, F., Yang, Z. H., & Yang, J. (2025) · World Allergy Organization Journal · doi:10.1016/j.waojou.2025.101089 · Cited by 1
“10 The protective role of IFN1 in anaphylaxis was fi rst reported over 3 decades ago; however, fi ndings have remained inconsistent.”
Antibiotic treatment limits survival of peripheral and bone marrow B-cell populations
Sanning, L. S., Walker, F. C., Maknojia, A., Wang, L., Jin, H., Kalugotla, G., Lovato, C., King, K. Y., & Baldridge, M. T. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024013694 · Cited by 1
Venugopala, K. N. (2025) · Asian Journal of Chemistry · doi:10.14233/ajchem.2025.34966 · Cited by 1
Flavonoids improve neurotransmitters for Parkinson’s treatment: mechanism and therapeutic potential
Zhang, Y., Bu, Y., Song, M., Hao, Z., & Chen, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1799142 · Cited by 2
“…constraints, advanced delivery platforms—such as nanoformulations—are being developed to enhance solubility, stability and tissue targeting, thereby improving the prospects for harnessing flavonoids in disease prevention and therapy (Chen et al., 2022; Steed et al., 2017; Chalet et al., 2018).”
Kanda, R., Kubo, S., Yamagata, K., Iwata, S., Todoroki, Y., Ueno, M., Nagayasu, A., Satoh, Y., Miyagawa, I., Sonomoto, K., et al. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110706 · Cited by 1
Homoisoflavonoids—From Natural Specificity and Biosynthesis to Precision Health‐Promoting Mechanisms
Zhang, J., Chen, H., Si, J., Han, Z., & Zhang, X. (2026) · Food Frontiers · doi:10.1002/fft2.70282 · Cited by 1
Gut Microbiota and Probiotics in Influenza: A Narrative Review of Mechanisms and Emerging Evidence
Guan, F., Zhang, J., Tian, Y., FU, B., Liu, J., Song, Y., Yan, A., Zhang, B., Chen, L., Min, Z., et al. (2026) · Viruses · doi:10.3390/v18050553 · Cited by 1
“…to influenza virus occurs within the lungs, substantial evidence indicates that gut microbiota and their metabolic products, such as short-chain fatty acids (SCFAs), are integral to the host’s immune regulation throughout the disease course—affecting both innate and adaptive immunity [16–18].”
Hu, M.-J., Yang, Y.-L., Yang, Y.-X., Zhang, R., Guo, T.-K., Xing, J.-H., Liu, B., Riaz, M. A., Yang, Y.-S., Yu, L.-J., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01025-4 · Cited by 1
Biological Rhythms in Coronavirus Pneumonia Pathogenesis
Mok, H., Gierasch, C. M., Ostendorf, E., Jaiswal, A., Adler, A. J., Ganninger, A., Wright, L., Ganninger, A., Fox, C., Hyrc, K. L., et al. (2026) · Journal of Biological Rhythms · doi:10.1177/07487304261449284 · Cited by 1
“Although littermate controls were used in all experiments, we did not assess microbiome composition in our animals, which could affect the outcomes of murine viral pneumonia (Steed et al., 2017).”
Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity
Wang, X. W., Day, C., & Koonin, E. V. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00948-6 · Cited by 1
“Furthermore, microbiota-derived desaminotyrosine can modulate host antiviral immunity through metabolite-mediated signalling, rather than direct microbial sensing, by enhancing type I IFN signalling, and thereby increasing resistance to influenza virus infection 183 .”
Gut–lung axis in radiation-induced lung injury: mechanisms and interventions
Zhou, P., Jiang, X., Zhang, H., Jiang, S., Zhang, X., Ma, C., & Bai, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1806833 · Cited by 1
“Although direct RILI-speci fi c models remain limited, colonization with C. orbiscindens or DAT supplementation replicated these protective effects in viral lung injury models, suggesting translational potential for radiation contexts (50, 51).”
The Gut Microbiome Drives Endogenous T-cell Activation Following CAR T-cell Therapy
Hu, K., Jin, L., Feng, Z., Yu, Q., Si, X., Ding, L., Han, Y., Zhu, M., Shi, C., Zeng, X., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1230 · Cited by 1
Yuan, H., LI, B. C., Shen, C., Xie, L., & Hou, F. (2026) · Microorganisms · doi:10.3390/microorganisms14081758 · Cited by 1
“Commensal signals also support inflammasome activation, dendritic cell migration and virus-specific T-and B-cell responses [19], whereas the microbial metabolite desaminotyrosine augments type I interferon-mediated protection [65].”
Mattioli, R., Risola, D. D., Sivori, F., Franzese, O., Genovese, I., Mastromarino, P., & Mosca, L. (2026) · Microorganisms · doi:10.3390/microorganisms14081771 · Cited by 1
“Microbial metabolites produced by intestinal microorganisms (e.g., desaminotyrosine, short-chain fatty acids) are able to stimulate the lung’s production of type I interferons, with known antiviral activity [6,7,13].”
Babu, P., Prakash, V., Subhash, S., Vanuopadath, M., Haripriyan, J., Rajan, K., Anu, A. G., Padmakumar, S., Kumar, G. B., Nair, B. G., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1905445 · Cited by 1
El‐Saadony, M. T., Saad, A. M., Fahmy, M. A., Mohammed, D. M., Khodeer, D. M., Alyami, E. M., Alkafaas, S. S., Dladla, M., Ghosh, S., Al‐Najjar, M. A. A., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1801674 · Cited by 1
Gut microbiota-derived metabolites in host physiology
Strati, F., & Facciotti, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85062-9.00014-3 · Cited by 4
The gut microbiome and severity of SARS-CoV-2 infection: what is the link?
Robalino, J. G., Salazar, P., Muñóz, N., Tene, D. M., & Pedreáñez, A. B. (2022) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2022.253262 · Cited by 1
The therapeutic role of microbial metabolites in human health and diseases
Manoharan, N., Parasuraman, R., Jayamurali, D., & Govindarajulu, S. N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90113-0.00002-x · Cited by 2
Soldatova, O. V., Goryanskaya, I. Y., ZAKHARYAN, E. A., & Сергеевна, И. В. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-207-11-86-93 · Cited by 1
Microbiome and Neurological Disorders
Ijaz, M. U., Akbar, A., Ashraf, A., Yeni, D. K., Naz, H. U., & Shahid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_9 · Cited by 3
Potential of a yogurt enriched with synbiotics for influenza prevention and treatment
Song, L., Liu, B., Huang, Y., Zhao, J., Li, X., Qiao, W., He, S., Ma, H., Liu, Y., Nie, W., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250326 · Cited by 1
Waterhouse, J. C. (2020) · Authorea · doi:10.22541/au.158758665.58622495 · Cited by 1
“In a mouse model, the commensal bacteria, Clostridium orbiscendins, produces desaminotyrosine, which primes Type I interferon signaling, thus mediating protection from influenza[20].”
Ichinohe, T., Nagai, M., Moriyama, M., Ishii, C., Mori, H., Watanabe, H., Nitta, Y., Arimitsu, N., Nishimoto, M., Nakahara, T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1737468/v1 · Cited by 1
Neutrophils repurpose the nucleolus as a cytokine reservoir and secretory organellePreprint
Xu, S., Smirnov, A., Kinsella, R. L., Rankin, A. N., Wise, A. D., Alexander, J. M., Patty, B. J., Mikhail, S. M., Bello, R. M., Kreamalmeyer, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.726057 · Cited by 1
Papers of note in Science 357 (6350)
Ferrarelli, L. K. (2017) · Science Signaling · doi:10.1126/scisignal.aao5735
The influence of the gut microbiota on influenza vaccine-induced immunity
Mooney, A. (2018) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17131847.v1
Nagai, M., Moriyama, M., & Ichinohe, T. (2020) · Research Square · doi:10.21203/rs.3.rs-129105/v1
Sustainable Synthesis of Amides from Ethyl 3‐(4‐Hydroxyphenyl) Propionate
Lima, R. N., Vaz, A. D. L. L., Clososki, G. C., & Porto, A. L. M. (2021) · ChemistrySelect · doi:10.1002/slct.202100883
Chai, J. (2020) · Journal of the Arkansas Academy of Science
Gut microbiota and brain function and pathophysiology
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00014-1
Silva-Angulo, F., Henao-Tamayo, M., Weir, T., Abdo, Z., & Izzo, A. (2021) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.03217 · Cited by 1
5089 回復期リハビリテーション病棟における患者の生活とその変容について : 患者の生活からみた回復期リハビリテーション病院の病棟計画に関する研究(その2)(病棟(1),建築計画I)
申, 錦., 芦沢, 由., 筧, 淳., 井上, 由., & 上野, 淳. (2005) · e+i Elektrotechnik und Informationstechnik · Cited by 1
Nagai, M., Moriyama, M., & Ichinohe, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.25.424300
“In addition, previous studies have demonstrated that gut commensal microbiota play a key role in innate and adaptive immune defense against influenza virus infection (Abt et al., 2012; Bradley et al., 2019; Ichinohe et al., 2011; Rosshart et al., 2017; Steed et al., 2017; Stefan et al., 2020).”
BackgroundResultImproved reconstruction of molecular networks with Gaussian graphical models
Bernal, V. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.207797647
Simeonov, A. M., & Auld, D. (2017) · Assay and Drug Development Technologies · doi:10.1089/adt.2017.29066.lit
Metadata
- Authors
- Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., Boon, A. C. M., Lenschow, D. J., & Stappenbeck, T. S.
- Affiliations
- Washington University in St. Louis (US)
- ITMO University (RU)
- Corresponding author
- Stappenbeck, Thaddeus S.
- ORCID
- Venue
- Science
- Published
- 2017-08-04
- Volume
- 357
- Issue
- 6350
- Pages
- 498-502
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5753406
- OpenAlex
- W2743370588
- Cited by
- 569
- References
- 55
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 68 · 2023: 74 · 2022: 80 · 2021: 94 · 2020: 78 · 2019: 37 · 2018: 29 · 2017: 8
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Crohn’s Colitis (award312855)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Keywords
- influenza, type I interferon, gut microbiota, microbial metabolites, plant flavonoids, Clostridium, antibiotic-induced dysbiosis, antiviral immunity, phagocytes, inflammation, plant-based diet
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Line, Clostridium perfringens, Interferon Type I, Lung, Orthomyxoviridae Infections, Phenylpropionates, Signal Transduction, Mice, Knockout, GTP-Binding Proteins, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.